In-depth effectiveness and safety of nintedanib in treating idiopathic pulmonary fibrosis: An Indian single-center observational study
Vivek Gupta
Numerous clinical trials have proven nintedanib's efficacy and safety in the treatment of Idiopathic Pulmonary Fibrosis (IPF). The purpose of this study is to evaluate nintedanib's effectiveness and safety in Indian patients with IPF.
ఇండెక్స్చేయబడింది
అసోకేషన్స్, సొసైటీలు మరియు యూనివర్శిటీల కోసం పీర్ రివ్యూ పబ్లిషింగ్